Medtronic plc.

Open: 86.08 Close: 84.99 Change: -1.09

Don't invest in Medtronic plc. Company Inc before reading this automated analysis produce by an AI.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, dividend, year, MDT, company, fiscal, Medtronics, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic closed $7.03 below its 52-week high ($92.02), which the company reached on May 3rd.02. Board of directors approved the companys cash dividend on Thursday, December 7, 2023, approved the companys annual revenue of $31.23B, a decrease of -1.45% In February 2024, the company has a market cap of $114.58B after eliminating 42, forming doubling looking Atkinson Femalereetpin socio

Today's News

Medtronic to announce financial results for its third quarter of fiscal year 2024 on February 20, 2024. The company will host a video webcast at 7:00 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch. Medtronics closed $7.03 below its 52-week high ($92.02), which the company reached on May 3rd.02. Medtronic plc (NYSE: MDT) announces cash dividend for third quarter of fiscal year 2024. Board of directors approved the companys cash dividend on Thursday, December 7, 2023, approved the companys cash dividend. Medtronic (MDT) stands at $86.18, denoting a -1.12% change from the preceding trading day. In the fiscal year ending April 28, 2023, Medtronics had annual revenue of $31.23B, a decrease of -1.45%. In February 2024, the company has a market cap of $114.58 Billion. Medtronic requires new hires to provide vaccination status against COVID-19 as of their start date. This requirement is a condition of employment. Medtronic named one of Americas Most JUST Companies. Just Capital, in collaboration with CNBC, released its annual JUST 100 list, recognizing American corporate leadership on business issues prioritized by the public. Medtronic MDT has 47 consecutive years of increasing dividends. The company has been rated with an A+ rating, indicating a strong financial position and the ability to sustain its dividend payments for the foreseeable future. The dividend payout has steadily increased over the past three years, reflecting its commitment to rewarding shareholders. Medtronic MDT offers the potential for reliable income throughout retirement. By investing in Medtronics MDT and leveraging its consistent dividend payments, investors can work towards maximizing their income goals.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, dividend, year, MDT, company, fiscal, Medtronics, and the most common words in the summary are: medtronic, mdt, stock, dividend, job, market, important, . One of the sentences in the summary was: Medtronic closed $7.03 below its 52-week high ($92.02), which the company reached on May 3rd.02. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #mdt #stock #dividend #job #market #important.